Who has invested in Insulet?

Deerfield Management, OrbiMed, TIAA are named among the investors backing Insulet.

Insulet Funding: $120M Raised, IPO

Insulet funding overview

Insulet is based in Acton, Massachusetts. Insulet has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO. Investors on record include Deerfield Management, OrbiMed, TIAA. 3 distinct backers are named across the disclosed rounds.

Insulet at a glance

Total raised: $120M
Latest round: IPO
Headquarters: Acton, Massachusetts
Notable investors: Deerfield Management, OrbiMed, TIAA

Frequently asked about Insulet funding

How much has Insulet raised?: Insulet has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Insulet?: Deerfield Management, OrbiMed, TIAA are named among the investors backing Insulet.
What was the latest Insulet funding round?: The most recent disclosed round is an IPO.
Where is Insulet based?: Insulet is based in Acton, Massachusetts.

Round data for Insulet is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Acton and backer lists below.

Insulet Funding: $120M Raised, IPO

Insulet funding overview

Insulet at a glance

Frequently asked about Insulet funding

Companies related to Insulet (18)

Browse related funding lists (3)